Cargando…
Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896506/ https://www.ncbi.nlm.nih.gov/pubmed/33637468 http://dx.doi.org/10.1016/j.transci.2021.103105 |
_version_ | 1783653557176631296 |
---|---|
author | Gambacorti-Passerini, Carlo Ruggeri, Marco Aroldi, Andrea Piazza, Rocco Mazzi, Angela De Silvestro, Giustina Krampera, Mauro Lanza, Francesco |
author_facet | Gambacorti-Passerini, Carlo Ruggeri, Marco Aroldi, Andrea Piazza, Rocco Mazzi, Angela De Silvestro, Giustina Krampera, Mauro Lanza, Francesco |
author_sort | Gambacorti-Passerini, Carlo |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7896506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78965062021-02-22 Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies Gambacorti-Passerini, Carlo Ruggeri, Marco Aroldi, Andrea Piazza, Rocco Mazzi, Angela De Silvestro, Giustina Krampera, Mauro Lanza, Francesco Transfus Apher Sci Letter to the Editor Elsevier Ltd. 2021-06 2021-02-20 /pmc/articles/PMC7896506/ /pubmed/33637468 http://dx.doi.org/10.1016/j.transci.2021.103105 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Gambacorti-Passerini, Carlo Ruggeri, Marco Aroldi, Andrea Piazza, Rocco Mazzi, Angela De Silvestro, Giustina Krampera, Mauro Lanza, Francesco Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies |
title | Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies |
title_full | Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies |
title_fullStr | Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies |
title_full_unstemmed | Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies |
title_short | Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies |
title_sort | transfusion of blood products derived from sars-cov-2+ donors to patients with hematological malignancies |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896506/ https://www.ncbi.nlm.nih.gov/pubmed/33637468 http://dx.doi.org/10.1016/j.transci.2021.103105 |
work_keys_str_mv | AT gambacortipasserinicarlo transfusionofbloodproductsderivedfromsarscov2donorstopatientswithhematologicalmalignancies AT ruggerimarco transfusionofbloodproductsderivedfromsarscov2donorstopatientswithhematologicalmalignancies AT aroldiandrea transfusionofbloodproductsderivedfromsarscov2donorstopatientswithhematologicalmalignancies AT piazzarocco transfusionofbloodproductsderivedfromsarscov2donorstopatientswithhematologicalmalignancies AT mazziangela transfusionofbloodproductsderivedfromsarscov2donorstopatientswithhematologicalmalignancies AT desilvestrogiustina transfusionofbloodproductsderivedfromsarscov2donorstopatientswithhematologicalmalignancies AT kramperamauro transfusionofbloodproductsderivedfromsarscov2donorstopatientswithhematologicalmalignancies AT lanzafrancesco transfusionofbloodproductsderivedfromsarscov2donorstopatientswithhematologicalmalignancies |